{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:36:25Z","timestamp":1762864585902,"version":"build-2065373602"},"reference-count":11,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2002,11,1]],"date-time":"2002-11-01T00:00:00Z","timestamp":1036108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,11,1]],"date-time":"2002-11-01T00:00:00Z","timestamp":1036108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,11,30]],"date-time":"2014-11-30T00:00:00Z","timestamp":1417305600000},"content-version":"vor","delay-in-days":4412,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2002,11]]},"DOI":"10.1046\/j.1469-0691.2002.00461.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T07:26:43Z","timestamp":1047367603000},"page":"753-757","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Comparative in vitro activity of ertapenem against bacterial pathogens isolated from patients with lower respiratory tract infections"],"prefix":"10.1016","volume":"8","author":[{"given":"P.S.","family":"Hicks","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Pelak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.L.","family":"Woods","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.F.","family":"Bartizal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Motyl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1046\/j.1469-0691.2002.00461.x_bib1","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1128\/AAC.45.6.1915-1918.2001","article-title":"In vitro activities of ertapenem (MK-0826) against clinical bacterial isolates from 11 North American Centers","volume":"45","author":"Fuchs","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2002.00461.x_bib2","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1128\/AAC.45.6.1860-1867.2001","article-title":"In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia","volume":"45","author":"Livermore","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1046\/j.1469-0691.2002.00461.x_bib3","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/jac\/43.5.703","article-title":"In vitro antimicrobial activity of a new carbapenem, MK-0826 (L-749, 345) and provisional interpretive criteria for disc tests","volume":"43","author":"Fuchs","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1046\/j.1469-0691.2002.00461.x_bib4","series-title":"Program and Abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL","first-page":"22","article-title":"Pharmacokinetics of ertapenem in healthy young volunteers","author":"Majumdar","year":"2001"},{"key":"10.1046\/j.1469-0691.2002.00461.x_bib5","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1086\/313954","article-title":"Practice guidelines for the management of community-acquired pneumonia in adults","volume":"31","author":"Bartlett","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1046\/j.1469-0691.2002.00461.x_bib6","series-title":"Principles and practice of infectious diseases","first-page":"706","article-title":"Chronic bronchitis and acute infectious exacerbations","author":"Reynolds","year":"2000"},{"key":"10.1046\/j.1469-0691.2002.00461.x_bib7","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1086\/339543","article-title":"A prospective, multicenter, double-blind, randomized, comparative study to evaluate the efficacy, safety, and tolerability, and of ertapenem versus ceftriaxone in the treatment of community-acquired pneumonia in adults","volume":"34","author":"Ortiz-Ruiz","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1046\/j.1469-0691.2002.00461.x_bib8","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0149-2918(02)85044-5","article-title":"Safety and tolerability of ertapenem with lidocaine administered intramuscularly: results of a prospective, randomized, double-blind multicenter study","volume":"24","author":"Legua","year":"2002","journal-title":"Clin Ther"},{"key":"10.1046\/j.1469-0691.2002.00461.x_bib9","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1086\/514930","article-title":"Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis","volume":"27","author":"Chodosh","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1046\/j.1469-0691.2002.00461.x_bib10","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1128\/AAC.42.4.729","article-title":"Cefepime versus ceftriaxone for empiric treatment of hospitalized patients with community-acquired pneumonia","volume":"42","author":"Zervos","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"year":"2000","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","key":"10.1046\/j.1469-0691.2002.00461.x_bib11"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14626677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14626677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:16:22Z","timestamp":1761117382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14626677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11]]},"references-count":11,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2002,11]]}},"alternative-id":["S1198743X14626677"],"URL":"https:\/\/doi.org\/10.1046\/j.1469-0691.2002.00461.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"type":"print","value":"1198-743X"}],"subject":[],"published":{"date-parts":[[2002,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative in vitro activity of ertapenem against bacterial pathogens isolated from patients with lower respiratory tract infections","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1046\/j.1469-0691.2002.00461.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 European Society of Clinical Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}